Abstracts from the 13th International Conference on Cerebral Vascular Biology (CVB 2019)

  • PDF / 1,264,063 Bytes
  • 57 Pages / 595.276 x 790.866 pts Page_size
  • 92 Downloads / 167 Views

DOWNLOAD

REPORT


Fluids and Barriers of the CNS Open Access

MEETING ABSTRACTS

Abstracts from the 13th International Conference on Cerebral Vascular Biology (CVB 2019) Miami, FL, USA. 25-28 June 2019 Published: 20 June 2019 I1 13th International Conference on Cerebral Vascular Biology Michal Toborek University of Miami School of Medicine, Miami, FL Correspondence: Michal Toborek ‑ [email protected] Fluids and Barriers of the CNS 2019, 16(Suppl 1):I1 The 13th International Conference on Cerebral Vascular Biology (CVB 2019; http://www.CVB20​19.com) is being organized at the Marriott Miami Biscayne Bay hotel from June 25–28, 2019 in Miami, FL. The CVB conferences are bi-annual meetings that provide a forum for scientists from around the world to discuss their cutting edge research on cerebral vascular biology with a focus on CNS barriers, primarily the blood–brain barrier (BBB). CVB 2019 in Miami will be a continuation of a very successful conference series that was initiated in 1992. To emphasize the importance and international focus of the CVB series, the conferences rotate between North America, Europe, and Asia/Australia (1992, Duluth, MN; 1995, Paris, France; 1998, Salishan, OR; 2001, Cambridge, UK; 2003, Amarillo, TX; 2005, Muenster, Germany; 2007, Ottawa, Canada; 2009, Sendai, Japan; 2011, Leiden, The Netherlands; 2013, Montreal, Canada; 2015, Paris, France; 2017, Melbourne, Australia). Since the formation of the International Brain Barriers Society (IBBS) in 2006, CVB conferences are organized under the general auspices of the IBBS. CVB 2019 is being attended by scientists from a broad range of backgrounds and disciplines who share a common interest in cerebral vascular biology. By bringing together scientists from diverse backgrounds in basic, translational, and clinical research, the meeting promotes the emergence of common themes across cerebrovascular topics. This will structure strategies for successful therapeutic interventions in the brain diseases that have strong cerebrovascular components and/or are underlined by the dysfunction of the BBB. The overall goal of CVB 2019 is to serve as a catalyst for exchange of information on the latest scientific discoveries related to the bioengineering of the BBB, efficient drug delivery into the brain, and involvement of the BBB in the physiology and pathology of the brain, including neuroinfections, neurodegenerative diseases, and addiction research. Consistent with this goal, the conference is focused on current and future research surrounding cerebral vascular biology, such as biology and structure of the neurovascular unit and cell junction proteins, constructing and modeling the BBB, delivery of various types of drugs across the BBB, the role of brain barriers in the pathology of neurological diseases, and therapeutic strategies to reverse these diseases by targeting the brain barriers. Emphasis are being placed on integrative science, translational aspects, and clinical research on disorders involving cerebral

vasculature that can be applied to therapy. Other emergin